e-Diary in Heart Failure

Sponsor
University of California, San Francisco (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03452683
Collaborator
(none)
0
1
2
8
0

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the efficacy and feasibility of using a smartphone application to monitor symptoms and weight in patients with advanced heart failure.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Movn Mobile App
N/A

Detailed Description

Attention to symptoms of heart failure and weight gain are central tenets in heart failure patient education and self-care. A key self-care skill for heart failure patients is the early detection of subtle changes in symptoms. Daily diary use can be one method for patients to acknowledge and attend to their symptoms. This study is examining if the use of a diary in the form of an app on a mobile phone will improve patient outcomes. Participants will be randomized to one of two groups-- usual care or the Movn mobile application. Participants randomized to the mobile app will be asked to record their weight and any symptoms every day over the course of two months.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Use of a Symptom and Weight e-Diary Among Patients With Heart Failure
Anticipated Study Start Date :
Apr 1, 2018
Anticipated Primary Completion Date :
Oct 1, 2018
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Participants randomized to the Usual Care arm will receive educational handouts.

Experimental: Movn Mobile App

Participants randomized to the Movn Mobile App arm will have the Movn app downloaded to their cell phone. Participants will enter in their weight and symptoms into the app every day.

Behavioral: Movn Mobile App
Movn is a mobile application that is downloaded to a cell phone where participants can enter their weight and symptoms every day.

Outcome Measures

Primary Outcome Measures

  1. Change in Health Care Utilization [Health Care Utilization will be measured at two timepoints-- baseline and month 3.]

    Health Care Utilization will be measured by a questionnaire that asks about number of office visits, emergency room visits, and hospitalization in the last 60 days.

Secondary Outcome Measures

  1. Quality of Life [Quality of life will be measured at two timepoints-- baseline and month 3.]

    Quality of life will be measured by the 20-item Short Form Survey (SF-20). Scores range from 0 to 100 with high values indicating higher functioning.

  2. Depression [Depression will be measured at baseline and month 3.]

    Depression will be measured by the Patient Health Questionnaire (PHQ-9). Scores can range from 5 to greater than 20 with 5 indicating minimal symptoms and 20 indicating severe major depression.

  3. Satisfaction with the app [Satisfaction with the app will be measured at month 3.]

    Participation satisfaction with the mobile app will be assessed through individual interviews.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least 18 years old

  • History of symptomatic heart failure (Class III or IV)

  • Owns a smartphone or tablet compatible with the Movn mobile application

Exclusion Criteria:
  • Cognitive impairment

  • Lack of English proficiency/literacy

  • Clinically unstable (decompensated heart failure NYHA class 3-4; unstable arrhythmias, aortic stenosis, thrombophlebitis, dissecting aneurysm, or symptomatic anemia; active infection; uncontrolled blood pressure: resting diastolic higher than 100 mmHg, systolic greater than 180 mmHg; unstable angina, 2nd or 3rd degree heart block; or uncontrolled high grade exercise-induced ventricular ectopy or hemodynamically unstable)

Contacts and Locations

Locations

Site City State Country Postal Code
1 John Muir Medical Center Concord California United States 94520

Sponsors and Collaborators

  • University of California, San Francisco

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Linda Park, Assistant Professor, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT03452683
Other Study ID Numbers:
  • e-Diary in Heart Failure
First Posted:
Mar 2, 2018
Last Update Posted:
Jun 26, 2018
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 26, 2018